Companies Dominating the Interlaminar Device Landscape
- NuVasive, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zimmer Biomet
- Life Spine, Inc.
- Xtant Medical
- Alphatec Holdings, Inc.
- Amedica Corporation
- Paradigm Health System
- Bioventus LLC
- Medical Device Business Services, Inc.
- Meditech Spine, LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of interlaminar device is estimated at USD 693.15 million.
The interlaminar device market size was valued at USD 629.19 million in 2024 and is likely to cross USD 1.37 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037. Growing Cases of Sports Injuries and the growing advancements in spine surgery technologies across the globe will boost the market growth.
North America industry is anticipated to account for largest revenue share of 38% by 2037, impelled by rising adoption of interlaminar devices in the region.
The major players in the market are NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC
